Wen Fu1,2, Guo-Chang Liu2, Zhang Zhao2, Jinhong Zhu3, Wei Jia2, Shi-Bo Zhu2, Jin-Hua Hu2, Feng-Hua Wang2, Jing He2, Huimin Xia1,2. 1. Southern Medical University, Guangzhou, Guangdong, China. 2. Department of Pediatric Urology, Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. 3. Molecular Epidemiology Laboratory and Department of Laboratory Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Abstract
BACKGROUND: Wilms tumor (WT) is the most common urologic cancer in children. However, genetic bases underlying WT remain largely unknown. Previous studies indicated that Lin28 homolog B (LIN28B) level is significantly elevated in some WTs. Enforced expression of Lin28b during kidney development could induce WT. Genetic variations in the LIN28B gene may be related to WT susceptibility. METHOD: In this study, we aimed to assess the association between LIN28B gene polymorphisms and WT susceptibility in Chinese children. Four potentially functional polymorphisms in the LIN28B gene (rs314276 C>A, rs221634 A>T, rs221635 T>C and rs9404590 T>G) were genotyped in 145 cases and 531 cancer-free controls, using Taqman method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. RESULTS: Our results showed that the rs314276 CA genotype was associated with a decreased WT risk (CA vs CC: adjusted OR=0.65, 95% CI=0.43-0.98, P=.042). Moreover, we found that carriers of the 1-3 risk genotypes had a significantly increased WT risk when compared to the non-carriers (adjusted OR=1.51, 95% CI=1.03-2.20, P=.035). The association with risk genotypes was more predominant in children 18 month old or younger and in females. CONCLUSION: In summary, these results indicated that the LIN28B gene rs314276 C>A polymorphism alone and three combined polymorphisms may be able to modify WT susceptibility in Southern Chinese children. Our findings call for further validation in large studies with different ethnicities involved.
BACKGROUND:Wilms tumor (WT) is the most common urologic cancer in children. However, genetic bases underlying WT remain largely unknown. Previous studies indicated that Lin28 homolog B (LIN28B) level is significantly elevated in some WTs. Enforced expression of Lin28b during kidney development could induce WT. Genetic variations in the LIN28B gene may be related to WT susceptibility. METHOD: In this study, we aimed to assess the association between LIN28B gene polymorphisms and WT susceptibility in Chinese children. Four potentially functional polymorphisms in the LIN28B gene (rs314276 C>A, rs221634 A>T, rs221635 T>C and rs9404590 T>G) were genotyped in 145 cases and 531 cancer-free controls, using Taqman method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. RESULTS: Our results showed that the rs314276 CA genotype was associated with a decreased WT risk (CA vs CC: adjusted OR=0.65, 95% CI=0.43-0.98, P=.042). Moreover, we found that carriers of the 1-3 risk genotypes had a significantly increased WT risk when compared to the non-carriers (adjusted OR=1.51, 95% CI=1.03-2.20, P=.035). The association with risk genotypes was more predominant in children 18 month old or younger and in females. CONCLUSION: In summary, these results indicated that the LIN28B gene rs314276 C>A polymorphism alone and three combined polymorphisms may be able to modify WT susceptibility in Southern Chinese children. Our findings call for further validation in large studies with different ethnicities involved.
Authors: Lingeng Lu; Dionyssios Katsaros; Susan T Mayne; Harvey A Risch; Chiara Benedetto; Emilie Marion Canuto; Herbert Yu Journal: Carcinogenesis Date: 2012-07-20 Impact factor: 4.944
Authors: Jeffrey S Dome; Conrad V Fernandez; Elizabeth A Mullen; John A Kalapurakal; James I Geller; Vicki Huff; Eric J Gratias; David B Dix; Peter F Ehrlich; Geetika Khanna; Marcio H Malogolowkin; James R Anderson; Arlene Naranjo; Elizabeth J Perlman Journal: Pediatr Blood Cancer Date: 2012-12-19 Impact factor: 3.167
Authors: Daniela Perotti; Peter Hohenstein; Italia Bongarzone; Mariana Maschietto; Mark Weeks; Paolo Radice; Kathy Pritchard-Jones Journal: Mol Cancer Ther Date: 2013-11-20 Impact factor: 6.261
Authors: Clare Turnbull; Elizabeth R Perdeaux; David Pernet; Arlene Naranjo; Anthony Renwick; Sheila Seal; Rosa Maria Munoz-Xicola; Sandra Hanks; Ingrid Slade; Anna Zachariou; Margaret Warren-Perry; Elise Ruark; Mary Gerrard; Juliet Hale; Martin Hewitt; Janice Kohler; Sheila Lane; Gill Levitt; Mabrook Madi; Bruce Morland; Veronica Neefjes; James Nicholson; Susan Picton; Barry Pizer; Milind Ronghe; Michael Stevens; Heidi Traunecker; Charles A Stiller; Kathy Pritchard-Jones; Jeffrey Dome; Paul Grundy; Nazneen Rahman Journal: Nat Genet Date: 2012-04-29 Impact factor: 38.330
Authors: Sharon J Diskin; Mario Capasso; Robert W Schnepp; Kristina A Cole; Edward F Attiyeh; Cuiping Hou; Maura Diamond; Erica L Carpenter; Cynthia Winter; Hanna Lee; Jayanti Jagannathan; Valeria Latorre; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris Journal: Nat Genet Date: 2012-09-02 Impact factor: 38.330